Merck Stock Is Outperforming In A Volatile Market. This Trade Puts An 11% Return In Sight.

What: Merck stock has seen a significant surge in recent weeks, outperforming the market in a volatile period.
Why: The stock's resilience is attributed to its diversified portfolio, strong pipeline, and a recent deal with Ridgeback Biotherapeutics.
Signal: The stock's 11% return in sight is a clear signal of investor confidence in the company's growth prospects.
Target: Analysts are targeting a price of $**94.50** for Merck stock, indicating a potential upside of **11%**.
Risk: However, investors should be aware of the risks associated with the ongoing pandemic and potential regulatory challenges.